ArticleInternational journal of computer assisted radiology and surgery2026
TREAT-Netv2: regional wall motion-informed video-tabular fusion for ACS treatment prediction.
Article in International journal of computer assisted radiology and surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeAcute coronary syndrome (ACS) is a major cause of cardiovascular mortality. While coronary angiography enables definitive diagnosis and intervention, its invasiveness and limited availability delay treatment, disproportionately affecting rural and remote communities. Development of noninvasive, predictive tools for early revascularization may improve triage and outcomes.
methodsWe propose TREAT-Netv2, a regional wall motion-informed video-tabular fusion network for ACS treatment prediction that integrates echocardiograms (echo) and electronic medical records. The model extracts regional wall motion features from echo sequences and applies the transformer-based multiple instance learning to capture nuanced disease representations. TREAT-Netv2 does not require diagnostic details such as level of occlusion or ACS subtype, eliminating the need for additional procedures and improving its robustness.
resultsTREAT-Netv2 achieved an AUROC of 72.5% and balanced accuracy of 68.6%, outperforming unimodal, multimodal, and state-of-the-art baselines. ACS subgroup analysis showed that TREAT-Netv2 achieved the highest accuracy for non-ST-elevated myocardial infarction and unstable angina (NSTEMI/UA) patients, the most clinically challenging cases where the need for invasive intervention is often uncertain.
conclusionBy the complete elimination of ACS-specific diagnostic inputs and incorporation of transformer-based fusion, TREAT-Netv2 enables noninvasive and resource-free ACS risk stratification, particularly in clinically ambiguous cases. Our code will be made publicly available at URL: github.com/DeepRCL/TREAT-Netv2.
Indexed as
Identifiers
42084769What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.